Skip to main content
Erschienen in: Orthopädie & Rheuma 5/2018

08.10.2018 | Rheumatoide Arthritis | Fortbildung

Wichtiges zur Therapie vor, während und nach der Schwangerschaft

Rheumakranke Frauen: Kinderwunsch ist heutzutage meist erfüllbar

verfasst von: Dr. med. Dieter Schöffel

Erschienen in: Orthopädie & Rheuma | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Viele entzündliche Rheumaerkrankungen kommen bei Frauen häufiger vor als bei Männern. Manche dieser Erkrankungen beginnen oft im sogenannten gebärfähigen Alter. Dazu zählen unter anderen die rheumatoide Arthritis und der systemische Lupus erythematodes oder das axiale Befallsmuster der Spondyloarthritis. Modernen Therapieoptionen ist es zu verdanken, dass eine entzündlich rheumatische Erkrankung einer Frau heutzutage dem Wusch nach Kindern nicht mehr entgegensteht.
Literatur
1.
Zurück zum Zitat Chakravarty E, Clowse ME, Pushparajah DS, Mertens S, Gordon C. Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. BMJ Open 2014;4:1–10CrossRef Chakravarty E, Clowse ME, Pushparajah DS, Mertens S, Gordon C. Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. BMJ Open 2014;4:1–10CrossRef
2.
Zurück zum Zitat Skorpen CG, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75:795–810CrossRef Skorpen CG, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75:795–810CrossRef
3.
Zurück zum Zitat Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005;353:2539–49CrossRef Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005;353:2539–49CrossRef
4.
Zurück zum Zitat Jakobsson GL, Stephansson O, Askling J, Jacobsson LT. Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study. Ann Rheum Dis 2016;75:1838–42CrossRef Jakobsson GL, Stephansson O, Askling J, Jacobsson LT. Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study. Ann Rheum Dis 2016;75:1838–42CrossRef
5.
Zurück zum Zitat Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc Staff Meet Mayo Clinic 1938;13:161–7 Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc Staff Meet Mayo Clinic 1938;13:161–7
6.
Zurück zum Zitat Jethwa H, Lam S, Smith C, Giles I. Does Inflammatory Arthritis Really Improve during Pregnancy? a Systematic Review and Meta-Analysis. Arthritis Rheumatol 2016; 68 (suppl 10). ACR abstract 1517 Jethwa H, Lam S, Smith C, Giles I. Does Inflammatory Arthritis Really Improve during Pregnancy? a Systematic Review and Meta-Analysis. Arthritis Rheumatol 2016; 68 (suppl 10). ACR abstract 1517
7.
Zurück zum Zitat Jawaheer D, Zhu JL, Nohr AE, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011;63:1517–21CrossRef Jawaheer D, Zhu JL, Nohr AE, Olsen J. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011;63:1517–21CrossRef
8.
Zurück zum Zitat Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 2015;74:1836–41CrossRef Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 2015;74:1836–41CrossRef
9.
Zurück zum Zitat Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness?. Fertil Steril 2013;100:1590–3CrossRef Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness?. Fertil Steril 2013;100:1590–3CrossRef
10.
Zurück zum Zitat Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009;61:113–20CrossRef Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009;61:113–20CrossRef
11.
Zurück zum Zitat Flint J, Panchal S, Hurell A, van der Venne M, Gayed M, Schreiber K et al.; BSR and BHPR Standards, Guidelines and Audit Working Group. BSP and BHPR guideline on prescribing drugs in pregnancy and breastfeeding. Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016;55:1693–7CrossRef Flint J, Panchal S, Hurell A, van der Venne M, Gayed M, Schreiber K et al.; BSR and BHPR Standards, Guidelines and Audit Working Group. BSP and BHPR guideline on prescribing drugs in pregnancy and breastfeeding. Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016;55:1693–7CrossRef
12.
Zurück zum Zitat Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in Pregnancy. Scand J Reumatol 2010;39:99–108CrossRef Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in Pregnancy. Scand J Reumatol 2010;39:99–108CrossRef
13.
Zurück zum Zitat van den Brandt S, Zbinden A, Baeten D, Villiger PM, Ostensen M, Forger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther 2017;19:64–72CrossRef van den Brandt S, Zbinden A, Baeten D, Villiger PM, Ostensen M, Forger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther 2017;19:64–72CrossRef
14.
Zurück zum Zitat Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011;50:657–64CrossRef Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011;50:657–64CrossRef
15.
Zurück zum Zitat Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y et al. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017;356:j895CrossRef Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y et al. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017;356:j895CrossRef
16.
Zurück zum Zitat Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006;10:361–6CrossRef Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006;10:361–6CrossRef
17.
Zurück zum Zitat Hyrich KL, Verstappen SM. Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford) 2014;53:1377–85CrossRef Hyrich KL, Verstappen SM. Biologic therapies and pregnancy: the story so far. Rheumatology (Oxford) 2014;53:1377–85CrossRef
18.
Zurück zum Zitat Berthelsen BG, Fjeldsoe-Nielsen H, Nielsen CT, Hellmuth E. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breast-feeding. Rheumatology (Oxford) 2010;49:2225–7CrossRef Berthelsen BG, Fjeldsoe-Nielsen H, Nielsen CT, Hellmuth E. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breast-feeding. Rheumatology (Oxford) 2010;49:2225–7CrossRef
19.
Zurück zum Zitat Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N; Network of French Pharmacovigilance Centers et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheum 2014;66:1101–10CrossRef Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N; Network of French Pharmacovigilance Centers et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheum 2014;66:1101–10CrossRef
20.
Zurück zum Zitat Mariette X, Forger F, Abraham B, Flynn AD, Molto A, Flipo RM et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, multicenter, pharmacokinetic study. Annual European Congress of Rheumatology in Madrid 2017; EULAR Abstract 17-1640 Mariette X, Forger F, Abraham B, Flynn AD, Molto A, Flipo RM et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, multicenter, pharmacokinetic study. Annual European Congress of Rheumatology in Madrid 2017; EULAR Abstract 17-1640
21.
Zurück zum Zitat Clowse ME, Wolf DC, Golembesky A, Shaugnessy L, De Cuyper D, Froger F. Characteristics and outcomes of prospectively-reported pregnancies exposed to certolizumab pegol from a safety database. ACR/AHRP Annual Meeting 2015; Poster Session C, Abstract Number: 2523 Clowse ME, Wolf DC, Golembesky A, Shaugnessy L, De Cuyper D, Froger F. Characteristics and outcomes of prospectively-reported pregnancies exposed to certolizumab pegol from a safety database. ACR/AHRP Annual Meeting 2015; Poster Session C, Abstract Number: 2523
22.
Zurück zum Zitat Oliver A, Overton C. Diagnosis and management of miscarriage. Practitioner 2014;258:25–8PubMed Oliver A, Overton C. Diagnosis and management of miscarriage. Practitioner 2014;258:25–8PubMed
23.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects. Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008;57:1-5 Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects. Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008;57:1-5
24.
Zurück zum Zitat Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum 2017;46:740–5CrossRef Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum 2017;46:740–5CrossRef
25.
Zurück zum Zitat Clowse ME 2017 EULAR Poster SAT 046 und SAT 0119 Clowse ME 2017 EULAR Poster SAT 046 und SAT 0119
26.
Zurück zum Zitat Hotham N, Hotham A. Drugs in breastfeeding. Aust Prescr 2015;38:156–9CrossRef Hotham N, Hotham A. Drugs in breastfeeding. Aust Prescr 2015;38:156–9CrossRef
27.
Zurück zum Zitat Derendorf H, Ruebsamen K, Clarke L, Schaeffler A, Kirwan JR. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis. J Clin Pharmacol 2013;53:326–33CrossRef Derendorf H, Ruebsamen K, Clarke L, Schaeffler A, Kirwan JR. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis. J Clin Pharmacol 2013;53:326–33CrossRef
28.
Zurück zum Zitat Guettrot-Imbert G, Costedoat-Chalumeau N, Tincani A. EULAR Textbook on Rheumatic Diseases, BMJ Publishing 2012 Guettrot-Imbert G, Costedoat-Chalumeau N, Tincani A. EULAR Textbook on Rheumatic Diseases, BMJ Publishing 2012
29.
Zurück zum Zitat Flint J, Panchal S, Hurrell A et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404.CrossRef Flint J, Panchal S, Hurrell A et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404.CrossRef
Metadaten
Titel
Wichtiges zur Therapie vor, während und nach der Schwangerschaft
Rheumakranke Frauen: Kinderwunsch ist heutzutage meist erfüllbar
verfasst von
Dr. med. Dieter Schöffel
Publikationsdatum
08.10.2018
Verlag
Springer Medizin
Erschienen in
Orthopädie & Rheuma / Ausgabe 5/2018
Print ISSN: 1435-0017
Elektronische ISSN: 2196-5684
DOI
https://doi.org/10.1007/s15002-018-1443-0

Weitere Artikel der Ausgabe 5/2018

Orthopädie & Rheuma 5/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.